These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17502733)

  • 1. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda.
    Kagaayi J; Makumbi F; Nakigozi G; Wawer MJ; Gray RH; Serwadda D; Reynolds SJ
    AIDS; 2007 May; 21(9):1208-10. PubMed ID: 17502733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CD4 testing to a clinical subgroup of patients could limit unnecessary CD4 measurements, premature antiretroviral treatment and costs in Thyolo District, Malawi.
    Zachariah R; Teck R; Ascurra O; Humblet P; Harries AD
    Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):24-31. PubMed ID: 16202436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
    Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
    HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms.
    Nguyen RH; Gange SJ; Serwadda D; Kigozi G; Kiwanuka N; Sewankambo NK; Wabwire-Mangen F; Quinn TC; Wawer M; Gray RH
    Int J STD AIDS; 2006 Feb; 17(2):112-5. PubMed ID: 16464273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
    Susaengrat W; Mitchai M; Leerattanapetch N
    J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV in the tropics: staging in the resource-limited setting.
    Varughese JK; Rosenberg MG; Kim K
    Curr Opin Infect Dis; 2012 Oct; 25(5):477-83. PubMed ID: 22744319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.
    Moore D; Liechty C; Ekwaru P; Were W; Mwima G; Solberg P; Rutherford G; Mermin J
    AIDS; 2007 Mar; 21(6):713-9. PubMed ID: 17413692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations.
    Kouanfack C; Laborde-Balen G; Aghokeng AF; Bourgeois A; Dontsop M; Mben JM; Kazé S; Mpoudi-Ngolé E; Koulla-Shiro S; Delaporte E; Laurent C;
    Trop Med Int Health; 2010 May; 15(5):580-3. PubMed ID: 20214755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.
    Bishai D; Colchero A; Durack DT
    AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda.
    Were W; Moore D; Ekwaru P; Mwima G; Bunnell R; Kaharuza F; Rutherford G; Mermin J
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):47-53. PubMed ID: 19105878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need?
    Torpey K; Lartey M; Amenyah R; Addo NA; Obeng-Baah J; Rahman Y; Suzuki C; Mukadi YD; Colebunders R
    Int J STD AIDS; 2009 Jun; 20(6):395-8. PubMed ID: 19451324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of changing antiretroviral treatment eligibility criteria on patient load in Kampala, Uganda.
    Konde-Lule J; Makumbi F; Pakker N; Muyinda A; Mubiru M; Cobelens FG
    AIDS Care; 2011 Jan; 23(1):35-41. PubMed ID: 20924829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When to start antiretroviral therapy?
    Wilkin TJ; Gulick RM
    Clin Infect Dis; 2008 Dec; 47(12):1580-6. PubMed ID: 18990069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption in chronic HIV infection.
    Boschi A; Tinelli C; Ortolani P; Arlotti M
    HIV Med; 2008 Jan; 9(1):19-26. PubMed ID: 18199169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, Uganda.
    Spacek LA; Gray RH; Wawer MJ; Sewankambo NK; Serwadda D; Wabwire-Mangen F; Kiwanuka N; Kigozi G; Nalugoda F; Quinn TC;
    Int J STD AIDS; 2006 Feb; 17(2):116-20. PubMed ID: 16464274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?
    Mbanya D; Assah F; Ndembi N; Kaptue L
    Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.
    Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM
    HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.